Tesamorelin vs Ipamorelin

Proxiva Compliance DeskResearch-use standards and labelling

These two are frequently set against each other, and the framing is slightly wrong. They are not alternatives in the way two analgesics are alternatives; they are two different doors into the same room. Understanding that is most of what a comparison page can usefully offer.

How does each one work?

Tesa-morelin is an analogue of growth hormone releasing hormone, altered to resist the enzyme that clears the native signal within minutes. Without that modification the parent molecule is too short-lived to be useful as a research material. It engages the releasing-hormone receptor on the anterior pituitary.

Ipamorelin arrives at the same tissue by an unrelated route. It is a five-residue secretagogue that binds the ghrelin receptor, prompting release of hormone already synthesised and stored in the pituitary. Its notable characteristic is selectivity: it engages that one receptor with comparatively little activity elsewhere, which distinguishes it from earlier compounds in the same class that were considerably less discriminating.

Why are they combined rather than compared?

Because two complementary routes to the same output are additive in a way two competing compounds are not. This is the explicit rationale behind the paired preparations in this catalogue — CJC No Dac + Ipamorelin – 10mg pairs a releasing-hormone-receptor agent with the ghrelin-receptor agent at 10mg for $90, against $180 for the two components separately.

Worth stating clearly: the pairing exists because the mechanisms are complementary, not because any published study examined the pair as a formulation. A blend is a packaging decision. The literature a researcher finds will concern the individual compounds, and that remains true however sensible the pairing looks on a mechanism diagram.

What does ‘acts on the pituitary’ actually mean for interpretation?

It means the administered peptide is not the thing whose effects are observed. Both compounds cause the pituitary to release a hormone; the peptide itself clears quickly. Anything measured downstream belongs to the released hormone, and attributing it to the peptide is a category error that appears constantly in secondary sources.

The practical consequence for research design is that these compounds are studied through their output rather than their own presence, and that pharmacokinetic reasoning about the peptide tells you comparatively little about the timecourse of anything downstream. A researcher comparing the two on the basis of their own half-lives is measuring the wrong variable.

Which is better value?

The question does not resolve cleanly because the two are not interchangeable. Ipamorelin is cheaper in absolute terms at $40 for 5mg, and cheaper again per milligram at the 10mg vial ($7.00/mg against $8.00/mg). Tesamorelin at $90 is a different class of molecule and the per-milligram comparison across classes is not meaningful.

Tesamorelin is by a wide margin the more frequently ordered of the two here — 802 units against 202 — which is a fact about demand rather than about merit, but it is the kind of fact that comparison pages usually omit and that is checkable against a live catalogue.

What separates suppliers on a page like this

Composition and price are easy to publish and easy to copy. Documentation is neither. The axis on which suppliers in this market genuinely differ is what their certificate reports and whether it is published per batch rather than as a specimen. A specimen certificate demonstrates that a laboratory once tested something; a per-batch certificate tells you about the vial in your hand.

The fields worth checking, in rough order of how often they are missing: quantity per component for any blend, the analytical method named rather than implied, the testing laboratory identified, an endotoxin determination, and a date that corresponds to the batch rather than to the listing. Every batch sold here publishes its certificate on the test results page.

Two further notes on handling that apply to every compound referenced above. Lyophilised material ships dry and tolerates ambient transit; long-term storage is cold and dark. Bring a vial to room temperature before piercing the stopper, because solvent entering a cold vial invites condensation. Reconstitute with Bacteriostatic Water where more than one withdrawal is planned — the preservative is the entire reason to prefer it over sterile water — adding solvent down the wall rather than onto the cake, and swirling rather than shaking.

Why a blend name is not a specification

Almost every named preparation in this market — Wolverine, Glow, Klow and the rest — originated in forum usage rather than in any standards body. Nobody registered the name, nobody defined it, and no authority polices it. The practical consequence is that two suppliers can both list a product under the same name and ship vials that differ by a factor of two or more in total mass and in the ratio between components.

This is why composition published elsewhere for these names frequently describes well under half the totals quoted here, and it is why comparing two vendors on price alone produces a meaningless answer. A cheaper vial carrying the same name may simply contain less. The only comparison that means anything is milligrams of each named component against price, taken from each supplier's own published composition — and where a supplier does not publish per-component quantities, there is no comparison to make.

The same logic applies to any review or ranking of these products that does not state composition. A page comparing five vendors' versions of a named blend without listing what is in each one is comparing labels, not materials.

Reading a certificate without taking it on trust

Most certificates in this market are genuine and most are also thinner than they appear. Four habits separate a document that means something from one that merely exists. First, check that the batch or lot number on the certificate matches the number on the vial — a certificate that names no batch is a specimen, and a specimen tells you a laboratory once tested something. Second, check the date: a certificate predating the batch it purports to describe is a filing error at best. Third, read what was actually measured. “Purity >99%” by an unnamed method is a claim; “99.2% by RP-HPLC at 214nm” is a measurement. Fourth, look for what is absent — mass confirmation, endotoxin, and for any metal-containing complex the metal determination itself.

None of this requires analytical training. It requires reading the document as a record rather than as a reassurance, and noticing which fields are populated. A supplier publishing per-batch certificates with named methods is making a checkable commitment; one publishing a single undated specimen is not.

What this page does not claim

Nothing here describes an intended use in humans, and no outcome of any kind is asserted. The material is supplied for in-vitro laboratory and research use only. Where a mechanism is described it is described as reported in the literature for that compound, and the searches below return that literature directly — including whatever currently contradicts the framing above. Proxiva does not curate those results.

Where to read the primary literature

Proxiva does not summarise findings on behalf of a researcher. These are live searches against the two public registries, not curated citations — they return whatever is currently indexed, including results that contradict the framing above.

• PubMed: tesamorelin · ClinicalTrials.gov
• PubMed: ipamorelin · ClinicalTrials.gov
• PubMed: growth hormone releasing hormone analogue · ClinicalTrials.gov
• PubMed: ghrelin receptor secretagogue · ClinicalTrials.gov

Frequently asked questions

All materials listed are supplied strictly for in-vitro laboratory and research use. They are not drugs, foods or cosmetics, are not for human or veterinary use, and nothing on this page describes an intended use in humans. Figures quoted are catalogue list prices at the time of writing and change without notice.